genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Danaher
Danaher Selling Off Some Businesses to Sartorius for $750M, Tying the…
Natural Products
Schistosome Parasite Paralyzed by Chemical Produced by Tiny Aquatic Animal
News
Novel Inexpensive Technique Can Identify Aggressive Tumors
News
Puma Genomes Reflect Inbreeding, Highlight Rescue Options
News
Merck & Co. Eliminating 500 U.S. Sales, Commercial Jobs
Insights
Insights
Top 10 Asia Biopharma Clusters 2019
Tech Exclusives
Genome Editing Heads to Primetime
On Your Radar
From Poetry to Policy: An Interview with Bartha Maria Knoppers
Commentary
Successfully Addressing the Challenges of Glycosylation
Brexit
Top 10 European Biopharma Clusters
A-Lists
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
Insights
Top 10 U.S. Biopharma Clusters
Insights
10 Takeover Targets to Watch This Fall
Insights
What the Top 10 Biopharma CEOs Are Making
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Tech Exclusives
Genome Editing Heads to Primetime
Danaher
Danaher Selling Off Some Businesses to Sartorius for $750M, Tying the…
Natural Products
Schistosome Parasite Paralyzed by Chemical Produced by Tiny Aquatic Animal
News
Novel Inexpensive Technique Can Identify Aggressive Tumors
Magazine
All
Supplement
October 2019 Vol. 39 No. 10
Better Living through Molecular Neuropharmacology
October 2019 Vol. 39 No. 10
CRISPR Dx May Help Nix Disease
Tech Exclusives
Modular Bioprocessing Makes Adaptability a Snap
Tech Exclusives
A Nanomedicine Technology Sampler Pack
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
Vaccinating the World One Collaboration at a Time
eBooks
Better Research Begins with an Experienced Solution Provider
Upcoming Webinars
A Cultured Life: Innovations in Spheroid and Organoid Models
Posters
Microfluidic Diffusional Sizing: A Novel Method for Characterizing Protein Interactions
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Companies
AstraZeneca
AstraZeneca
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AstraZeneca
AveXis to Acquire AstraZeneca Manufacturing Site in Longmont, CO
AstraZeneca
AstraZeneca, Daiichi Sankyo Launch Potentially $6.9B+ Collaboration to Develop Cancer ADC
AstraZeneca
Moderna Raises Size of its Largest-Ever Biotech IPO to $600M
AstraZeneca
AstraZeneca’s Imfinzi Fails 2nd Primary Endpoint in Phase III MYSTIC Trial
AstraZeneca
Sobi Buys Synagis U.S. Rights, Half Share of MEDI18897 U.S. Profits from AstraZeneca
AstraZeneca
Grünenthal Acquires Partial Rights to Nexium, Vimovo from AstraZeneca for Up-to-$922M
AstraZeneca
After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans...
AstraZeneca
AstraZeneca Weighs Expanding Fasenra to COPD after Phase III Failure
AstraZeneca
AstraZeneca, SWIBCo Launch Stem Cell Cardiovascular Therapy Collaboration
AstraZeneca
After Patient Dies, FDA Imposes Clinical Hold on Trial of Advaxis/AstraZeneca...
AstraZeneca
With $250M in Financing, AstraZeneca Spinout to Focus on Severe Autoimmune...
AstraZeneca
Bavarian Nordic Launches Study of Cancer Vaccine CV301 with AstraZeneca’s Imfinzi
AstraZeneca
Moderna Raises $500M Financing for mRNA R&D, Manufacturing
AstraZeneca
Regeneron to Lead $50M Exome Sequencing Consortium with UK Biobank
AstraZeneca
PhaseBio Inks License to Develop MedImmune’s Reversal Agent for Blood Thinner
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
